Literature DB >> 11028578

Expectant management of early onset, severe pre-eclampsia: perinatal outcome.

D R Hall1, H J Odendaal, G F Kirsten, J Smith, D Grové.   

Abstract

OBJECTIVE: To evaluate the perinatal outcome of expectant management of early onset, severe pre-eclampsia.
DESIGN: Prospective case series extending over a five-year period.
SETTING: Tertiary referral centre. POPULATION: All women (n = 340) presenting with early onset, severe pre-eclampsia, where both mother and the fetus were otherwise stable.
METHODS: Frequent clinical and biochemical monitoring of maternal status with careful blood pressure control. Fetal surveillance included six-hourly heart rate monitoring, weekly Doppler and ultrasound evaluation of the fetus every two weeks. All examinations were carried out in a high care obstetric ward. MAIN OUTCOME MEASURES: Prolongation of gestation, perinatal mortality rate, neonatal survival and major complications.
RESULTS: A mean of 11 days were gained by expectant management. The perinatal mortality rate was 24/1,000 (> or = 1,000 g/7 days) with a neonatal survival rate of 94%. Multivariate analysis showed only gestational age at delivery to be significantly associated with neonatal outcome. Chief contributors to neonatal mortality and morbidity were pulmonary complications and sepsis. Three pregnancies (0.8%) were terminated prior to viability and only two (0.5%) intrauterine deaths occurred, both due to placental abruption. Most women (81.5%) were delivered by caesarean section with fetal distress the most common reason for delivery. Neonatal intensive care was necessary in 40.7% of cases, with these babies staying a median of six days in intensive care.
CONCLUSION: Expectant management of early onset, severe pre-eclampsia and careful neonatal care led to high perinatal and neonatal survival rates. It also allowed the judicious use of neonatal intensive care facilities. Neonatal sepsis remains a cause for concern.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028578     DOI: 10.1111/j.1471-0528.2000.tb11617.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  13 in total

1.  Maternal and perinatal outcome during expectant management of severe pre-eclampsia between 24 and 34 weeks of gestation.

Authors:  M K Swamy; Kamal Patil; Shailaja Nageshu
Journal:  J Obstet Gynaecol India       Date:  2012-10-23

2.  The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia.

Authors:  Renate Hillermann; Kashefa Carelse; G Stefan Gebhardt
Journal:  J Hum Genet       Date:  2005-07-30       Impact factor: 3.172

3.  Lactic dehydrogenase: a biochemical marker for preeclampsia-eclampsia.

Authors:  S P Jaiswar; Amrit Gupta; Rekha Sachan; S N Natu; Mohan Shaili
Journal:  J Obstet Gynaecol India       Date:  2012-01-04

4.  Does aggressive and expectant management of severe preeclampsia affect the neurologic development of the infant?

Authors:  Arif Aktuğ Ertekin; Bilge Kapudere; Meryem Kurek Eken; Gülşah İlhan; Şükriye Dırman; Mehmet Akif Sargın; Engin Deniz; Güner Karatekin; Ebru Çöğendez; Murat Api
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Annexin A1 Is Increased in the Plasma of Preeclamptic Women.

Authors:  Luiza O Perucci; Fernanda S Carneiro; Cláudia N Ferreira; Michelle A Sugimoto; Frederico M Soriani; Gustavo G Martins; Kátia M Lima; Flávia L Guimarães; Antônio L Teixeira; Luci M Dusse; Karina B Gomes; Lirlândia P Sousa
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

6.  Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia?

Authors:  Mi Jung Kim; Young Nam Kim; Eun Jung Jung; Hye Ree Jang; Jung Mi Byun; Dae Hoon Jeong; Moon Su Sung; Kyung Bok Lee; Ki Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2017-05-15

7.  sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).

Authors:  A Perales; J L Delgado; M de la Calle; J A García-Hernández; A I Escudero; J M Campillos; M D Sarabia; B Laíz; M Duque; M Navarro; P Calmarza; M Hund; F V Álvarez
Journal:  Ultrasound Obstet Gynecol       Date:  2017-09       Impact factor: 7.299

8.  Evaluation of serum biomarkers for detection of preeclampsia severity in pregnant women.

Authors:  Maryam Kasraeian; Nasrin Asadi; Homeira Vafaei; Tarlan Zamanpour; Hadi Raeisi Shahraki; Khadije Bazrafshan
Journal:  Pak J Med Sci       Date:  2018 Jul-Aug       Impact factor: 1.088

9.  Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction.

Authors:  Jeanne Sibiude; Jean Guibourdenche; Marie-Danielle Dionne; Camille Le Ray; Olivia Anselem; Raphaël Serreau; François Goffinet; Vassilis Tsatsaris
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

10.  Assessment of prevalence of preeclampsia from Dilla region of Ethiopia.

Authors:  Prabhanjan Kumar Vata; Nitin M Chauhan; Arasumani Nallathambi; Fentaw Hussein
Journal:  BMC Res Notes       Date:  2015-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.